|
مقاله
|
Abstract
|
|
|
|
Title:
|
Comparing the effect of intravitreal bevacizumab in diabetic macular edema with and without epimacular membranes
|
|
Author(s):
|
Khalil Ghasemi Falavarjani MD, Mehdi Modarres MD, Mohammad Mehdi Parvaresh MD, Tafgeh Mohammadi MD, Maryam Ashraf MD, Mahmoud Motallebi MD, Sayyed Amirpooya Alemzadeh MD, Ahad Sedaghat MD, Pasha Anvari MD
|
|
Presentation Type:
|
Poster
|
|
Subject:
|
Posterior Segment
|
|
Others:
|
|
|
Presenting Author:
|
|
|
Name:
|
Pasha Anvari
|
|
Affiliation :(optional)
|
Eye research Center, Rassoul Akram Hospital, Iran University of Medical Sciences.
|
|
E mail:
|
anvari.pasha@gmail.com
|
|
Phone:
|
88010558
|
|
Mobile:
|
09122490767
|
|
|
|
|
Purpose:
|
To compare the effect of intravitreal bevacizumab injection on central macular thickness in patients with clinically significant macular edema (CSME) with and without epiretinal membrane (ERM).
|
|
Methods:
|
In this prospective interventional comparative study, intravitreal bevacizumab injections were performed in patients with CSME with and without ERM. The anatomical and visual outcomes were compared in patients with and without ERM.
|
|
Results:
|
Fifty patients were included. There was no statistically significant reduction in central macular thickness (CMT) in the ERM group (? = 22 microns, P =0.07). CMT significantly decreased in the patients who did not have ERM (? = 57 microns, P =0.02). Patients with ERM had 0.09 Log MAR improvement in best corrected visual acuity (BCVA, P =0.001) in contrast to no significant change in BCVA of patients who did not have ERM (P =0.37).
|
|
Conclusion:
|
Intravitreal bevacizumab improved BCVA in patients who had CSME and ERM. However, in patients who had CSME without ERM, the reduction in CMT was not associated with any significant improvement in BCVA.
|
|
Attachment:
|
205bevz.pptx
|
|
|